These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 27799249)

  • 1. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
    Najjar YG; Rayman P; Jia X; Pavicic PG; Rini BI; Tannenbaum C; Ko J; Haywood S; Cohen P; Hamilton T; Diaz-Montero CM; Finke J
    Clin Cancer Res; 2017 May; 23(9):2346-2355. PubMed ID: 27799249
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses.
    Aggen DH; Ager CR; Obradovic AZ; Chowdhury N; Ghasemzadeh A; Mao W; Chaimowitz MG; Lopez-Bujanda ZA; Spina CS; Hawley JE; Dallos MC; Zhang C; Wang V; Li H; Guo XV; Drake CG
    Clin Cancer Res; 2021 Jan; 27(2):608-621. PubMed ID: 33148676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
    Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
    Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer.
    Yang L; Wang B; Qin J; Zhou H; Majumdar APN; Peng F
    Immunopharmacol Immunotoxicol; 2018 Feb; 40(1):91-97. PubMed ID: 29303012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-derived suppressor cell accumulation in renal cell carcinoma is correlated with CCL2, IL-17 and IL-18 expression in blood and tumors.
    Guan X; Liu Z; Zhang J; Jin X
    Adv Clin Exp Med; 2018 Jul; 27(7):947-953. PubMed ID: 29905412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
    Sun L; Clavijo PE; Robbins Y; Patel P; Friedman J; Greene S; Das R; Silvin C; Van Waes C; Horn LA; Schlom J; Palena C; Maeda D; Zebala J; Allen CT
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.
    Highfill SL; Cui Y; Giles AJ; Smith JP; Zhang H; Morse E; Kaplan RN; Mackall CL
    Sci Transl Med; 2014 May; 6(237):237ra67. PubMed ID: 24848257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
    Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY; Zebala JA; Clavijo PE; Allen C
    Clin Cancer Res; 2020 Mar; 26(6):1420-1431. PubMed ID: 31848188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
    Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
    Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.
    Wang G; Lu X; Dey P; Deng P; Wu CC; Jiang S; Fang Z; Zhao K; Konaparthi R; Hua S; Zhang J; Li-Ning-Tapia EM; Kapoor A; Wu CJ; Patel NB; Guo Z; Ramamoorthy V; Tieu TN; Heffernan T; Zhao D; Shang X; Khadka S; Hou P; Hu B; Jin EJ; Yao W; Pan X; Ding Z; Shi Y; Li L; Chang Q; Troncoso P; Logothetis CJ; McArthur MJ; Chin L; Wang YA; DePinho RA
    Cancer Discov; 2016 Jan; 6(1):80-95. PubMed ID: 26701088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma.
    Orillion A; Hashimoto A; Damayanti N; Shen L; Adelaiye-Ogala R; Arisa S; Chintala S; Ordentlich P; Kao C; Elzey B; Gabrilovich D; Pili R
    Clin Cancer Res; 2017 Sep; 23(17):5187-5201. PubMed ID: 28698201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.
    Kremer V; Ligtenberg MA; Zendehdel R; Seitz C; Duivenvoorden A; Wennerberg E; Colón E; Scherman-Plogell AH; Lundqvist A
    J Immunother Cancer; 2017 Sep; 5(1):73. PubMed ID: 28923105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.
    Cao M; Huang W; Chen Y; Li G; Liu N; Wu Y; Wang G; Li Q; Kong D; Xue T; Yang N; Liu Y
    Int J Cancer; 2021 Jul; 149(2):460-472. PubMed ID: 33751565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of IL-18-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy against osteosarcoma cancer.
    Guan Y; Zhang R; Peng Z; Dong D; Wei G; Wang Y
    J Bone Oncol; 2017 Nov; 9():59-64. PubMed ID: 29226090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.
    Wang Y; Zhang X; Yang L; Xue J; Hu G
    J Bone Oncol; 2018 Jun; 11():27-32. PubMed ID: 29892522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
    Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
    Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy.
    Foureau DM; Guo F; Steuerwald NM; Druhan LJ; Avalos BR; Copelan E; Sun D; Hu B; Moyo T; Jacobs R; Park S; Ghosh N
    Exp Hematol; 2024 Jan; 129():104125. PubMed ID: 38743005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function.
    Clavijo PE; Friedman J; Robbins Y; Moore EC; Smith E; Zauderer M; Evans EE; Allen CT
    Cancer Immunol Res; 2019 Feb; 7(2):282-291. PubMed ID: 30514791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.